What is Optipranolol used for?

Optipranolol is indicated for Ocular hypertension, Open-angle glaucoma.

Who makes Optipranolol?

Optipranolol is developed by Bausch Health.

What development phase is Optipranolol in?

Optipranolol is FDA-approved (marketed).

What is the generic name of Optipranolol?

METIPRANOLOL is the generic (nonproprietary) name of Optipranolol.

Last reviewed 2026-04-20 · How we verify

Optipranolol (METIPRANOLOL)

Bausch Health · FDA-approved withdrawn Small molecule Quality 24/100

Optipranolol (Metipranolol) is a small molecule beta-adrenergic blocker developed by Bausch and Lomb. It targets the beta-1 adrenergic receptor to treat ocular hypertension and open-angle glaucoma. As an off-patent medication, it is available as a generic option. Optipranolol is used to reduce intraocular pressure by decreasing the production of aqueous humor in the eye. It has been FDA-approved since 1989.

At a glance

Generic name	METIPRANOLOL
Sponsor	Bausch Health
Drug class	beta-Adrenergic Blocker
Target	Beta-1 adrenergic receptor
Modality	Small molecule
Therapeutic area	Cardiovascular
Phase	FDA-approved
First approval	1989

Approved indications

Ocular hypertension
Open-angle glaucoma

Common side effects

No common side effects on file.

Key clinical trials

Coreg and HSRs-Updated Analysis

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
FDA label	Mechanism, indications, dosing, boxed warnings, drug interactions
ClinicalTrials.gov	Trial enrolment, design, endpoints, results